[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2763692A - Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma - Google Patents

Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma

Info

Publication number
AU2763692A
AU2763692A AU27636/92A AU2763692A AU2763692A AU 2763692 A AU2763692 A AU 2763692A AU 27636/92 A AU27636/92 A AU 27636/92A AU 2763692 A AU2763692 A AU 2763692A AU 2763692 A AU2763692 A AU 2763692A
Authority
AU
Australia
Prior art keywords
asthma
treatment
adhesion molecules
intercellular adhesion
binding ligands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27636/92A
Inventor
Robert H. Gundel
Robert Rothlein
Craig D. Wegner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharmaceuticals Inc
Publication of AU2763692A publication Critical patent/AU2763692A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1777—Integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU27636/92A 1991-10-02 1992-10-02 Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma Abandoned AU2763692A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77004691A 1991-10-02 1991-10-02
US770046 1991-10-02

Publications (1)

Publication Number Publication Date
AU2763692A true AU2763692A (en) 1993-05-03

Family

ID=25087308

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27636/92A Abandoned AU2763692A (en) 1991-10-02 1992-10-02 Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma

Country Status (2)

Country Link
AU (1) AU2763692A (en)
WO (1) WO1993006842A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6130202A (en) * 1990-07-20 2000-10-10 Bayer Corporation Antiviral methods
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
JPH09512252A (en) * 1994-04-12 1997-12-09 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド Use of agents that block intercellular adhesion molecule / receptor interactions in the treatment of respiratory viral infections
GB9414966D0 (en) * 1994-07-26 1994-09-14 Danbiosyst Uk Pharmaceutical compositions for the nasal administration of antiviral agents
US5879712A (en) * 1995-06-07 1999-03-09 Sri International Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
US6391452B1 (en) 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations

Also Published As

Publication number Publication date
WO1993006842A1 (en) 1993-04-15

Similar Documents

Publication Publication Date Title
AU3482495A (en) Substituted heteroaromatic compounds and their use in medicine
AU6319294A (en) Intercellular adhesion molecules, and their binding ligands
AU2103097A (en) Cinnoline derivatives and use as medicine
AU3262395A (en) Superconducting cyclotron and target for use in the production of heavy isotopes
AU7806391A (en) Cationic microgels and their use in electrodeposition
CA2047721A1 (en) Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma
AU3666695A (en) Pyridazinones and their use as fungicides
EP0675120A3 (en) Use of ascorbyl-gamma-linolenate or a ascorbyl-dihomo-gamma-linolenate for the treatment of asthma, cancer, cardiovascular and inflammatory disorders
AU1180795A (en) Novel palladium complexes and methods for using same in the treatment of tumors and psoriasis
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
AU8487191A (en) 2-aminopyrimidine-4-caroxamide derivatives, their preparation and their use in therapy
HUP9903886A3 (en) Azacycloalcane derivatives, preparation thereof and their applications in therapy
AU4268496A (en) Targeting complexes and use thereof
AU2633288A (en) Intercellular adhesion molecules and their binding ligands
AU4347696A (en) Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
AU647382B2 (en) Intercellular adhesion molecules and their binding ligands
AU2763692A (en) Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma
AU6128896A (en) Isoindole derivatives, their preparation and their application in therapy
ZA901842B (en) Use of intercellular adhesion molecules,and their binding ligans in the treatment of asthma
AU1507992A (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their application in therapy
AU3634595A (en) Bis-oxazolidines and their use
AU1630697A (en) Use of naphthalene derivatives in treating lung carcinoma
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory
AU3315289A (en) Benzothiazepin-4-one derivatives, their preparation and their application in therapy
AU2905995A (en) Brefeldin A derivatives and their utility in the treatment of cancer